Blood cytokine levels rise even after minor surgical trauma

Journal of Clinical Immunology

Volumn 16, Issue 3, 1996, Pages 159-164

  Grzelak, Irena ^a   Olszewski, Waldemar L ^a   Zaleska, Marzanna ^a   Durlik, Marek ^a,c   Lagiewska, Beata ^b   Muszynski, Marek ^c   Rowinski, Wojciech ^b  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c Military Hospital Warszawa   (Poland)

Author keywords

Minor surgical trauma; Systemic cytokine production

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; PRIORITY JOURNAL; SURGICAL INJURY;

ADULT; AGED; CHOLECYSTECTOMY; CYTOKINES; HUMANS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, MINOR;

EID: 0029991739     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01540914     Document Type: Article

References (51)

1. Simone C, Pugnaloni L, Cilli A, Forastieri EMA, Bernardini B, Delogu G, Sorice F: Pharmacokinetic assessment of immunosuppressive activity of antibiotics in human plasma by modification of the mixed lymphoreaction. Crit Care Med 12:483-485, 1984
2. Salo M: Effects of anaesthesia and surgery on the immune response. Acta Anaesthesiol Scand 36:201-220, 1992
3. Calvano S: Hormonal mediation of immune dysfunction following thermal and traumatic injury. In Advances in Host Defence Mechanism, JM Davies, GT Shires (eds). New York, Raven Press, 1986, pp 111-142
4. Miller CL, Baker CC: Changes in lymphocyte activity after thermal injury. The role of suppressor cells. J Clin Invest 63:202-210, 1979
5. Munster AM: Post-traumatic immunosuppression is due to activation of suppressor T cells. Lancet 1:1329-1330, 1976
6. Wang BS, Heacock EH, Wu AVO, Mannick JA: Generation of suppressor cells in mice after surgical trauma. J Clin Invest 66:200-209, 1980
7. Winchurch RA, Munster AM: Post-traumatic activation of suppressor cells. J Reticuloendothel Soc 27:83-88, 1980
8. Constantin MB, Menzoian JO, Nimberg RB, Schmid K, Mannick JA: Association of a circulating immunosuppressive polypeptide with operative and accidental trauma. Ann Surg 185:73-79, 1977
9. Movat HZ: Tumor necrosis factor and interleukin-1: Role in acute inflammation and microvascular injury. J Lab Clin Med 110:668-681, 1987
10. Nishimoto N, Yoshizaki K, Tagoh H, Monden M, Kishimoto S, Hirano T, Kishimoto T. Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation. Clin Immunol Immunopathol 50:399-401, 1989
11. Green DR, Faist E: Trauma and immune response. Immunol Today 9:253-255, 1988
12. Akira S, Kishimoto T: IL6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 127:25-50, 1992
13. Heinrich PC, Castell JV, Andus T: Interleukin 6 and the acute phase response. Biochem J 265:621-636, 1990
14. Kelso A: Cytokines: Structure, function and synthesis. Current Opin Immunol 2:215-225, 1989
15. Arai K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: Coordinators of immune and inflammatory responses. Annu Rev Biochem 59:783-836, 1990
16. Marx JL: Cytokines are two-edged swords in disease. Science 239:257-258, 1988
17. Arend WP, Malyak M, Bigler CF, Smith MF, Janson RW: The biological role of naturally-occurring cytokine inhibitors. Br J Rheumatol 30:49-52, 1991
18. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC: Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336-340, 1990
19. McIntyre KW, Stepan GJ, Kokinsky KD, Benjamin WR, Plocinksy JM, Kaffka KL, Campen RA, Chizzonite RA, Killian PL: Inhibition of interleukin 1 (IL1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL1 receptor antagonist and anti-IL1 receptor monoclonal antibody. J Exp Med 173:931-939, 1991
20. Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC: Interleukin 1-receptor antagonist reduces mortality from endotoxin shock. Nature 348:550-552, 1990
21. Alexander HR, Doherty GM, Buresh CM, Venzon DJ, Norton JA: A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J Exp Med 173:1029-1032, 1991
22. Everaerdt B, Brouckaert P, Fiers W: Recombinant IL-1 receptor antagonist protects against TNF-induced lethality in mice. J Immunol 152:5041-5049, 1994
23. Arend WP: Interleukin-1 receptor antagonist: A new member of the interleukin 1 family. J Clin Invest 88:1546-1451, 1991
24. Dinarello CA, Thompson RC: Blocking IL-1: Interleukin-1 receptor antagonist in vivo and in vitro. Immunol Today 12:404-410, 1991
25. Zamir O, O'Brien W, Thompson R, Bloedow DC, Fischer JE, Hasselgren PO: Int Reduced muscle protein breakdown in septic rats following treatment with interleukin-1 receptor antagonist. J Biochem 26:943-950, 1994
26. Moldawer LL: Interleukin 1, TNF alpha and their naturally occurring antagonists in sepsis. Blood Purif 11:128-133, 1993
27. Tilg H, Trehu E, Atkins MB, Dinarello ChA, Mier JW: Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83:113-118, 1994
28. Rogy MA, Coyle SM, Olendburg HS, Rock CS, Barie PS, Van-Zee KJ, Smith CG, Moldauer LL, Lowry SF: Persistently elevated soluble tumor necrosis factor receptor and inlerleukin-1 receptor antagonist levels in critically ill patients. J Am Cell Surg 178:132-138, 1994
29. van Deuren M, van der Yen Jongekrijg J, Demacker PN, Bartelink AK, van Dalen R, Suuerweien RW, Gallali H, Vannice JL, van der Meer JW: Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infection. J Infect Dis 169:157-161, 1994
30. Akira S, Kishimoto T: IL6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 127:25-50, 1992
31. Heinrich PC, Castell JV, Andus T: Interleukin 6 and the acute phase response. Biochem J 265:621-636, 1990
32. Clark SC: Interleukin 6. Multiple activities in regulation of the hematopoietic and immune systems. Ann NY Acad Sci 557:438-443, 1989
33. Helle M, Brakenhoff JPJ, de Groot ER, Aarden LA: Interleukin 6 is involved in interleukin 1 induced activities. Eur J Immunol 18:957-959, 1988
34. Ashcroft GS, Masterson GS: Interleukin-6 and wound healing. Br J Anaesth 73:426-432, 1994
35. Zhou D, Munster AM, Winchurch RA: Inhibitory effects of interleukin 6 on immunity. Possible implications in burn patients. Arch Surg 127:65-69, 1992
36. May LT, Viguet H, Kenney JS, Ida N, Allison AC, Sehgal PB: High levels of "complexed" interleukin-6 in human blood. J Biol Chem 267:19698-19704, 1992
37. May LT, Neta R, Moldawer LL, Kenney JS, Palel K, Seghal PB: Antibodies chaperone circulating IL-6. Paradoxical effects of anti-IL6 "neutralizing" antibodies in vivo. J Immunol 151:3225-3236, 1993
38. Matsushima K, Oppenheim JJ: Interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL1 and TNF. Cytokine 1:2-13, 1989
39. Baggiolini M, Walz A, Kunkel SL: Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045-1049, 1989
40. Van Zee KJ, DeForge LE, Fischer E, Marano MA, Kenney JS, Remick DG, Lowry SF, Oldawer LL: IL8 in septic shock, endotoxemia, and after IL1 administration. J Immunol 146:3478-3482, 1991
41. Martich GD, Danner RL, Ceska M, Suffredini AF: Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: The effect of anti-inflummalory agents. J Exp Med 173:1021, 1991
42. Danner RL, Suffredini AF, Dervort AL, Ceska M, Stetz PL, Zablotny JA, Patterson EA: Detection of interleukin 6 (IL-6) and interleukin 8 (IL-8) during septic shock in humans. Clin Res 38:352A, 1990
43. Garner WL, Rodriguez JL, Miller C, Smith DJ, Remick DG: Acute skin injury releases neutrophil chemoattractants. Surg Forum 42:617-618, 1991
44. de Waal Malefyt R, Abrams J, Bennett B, Figdor CC, de Vries JE: Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991
45. Pradier O, Gerard C, Delvaux A, Lybin M, Abramowicz D, Capel P, Velu T, Goldman M: Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur J Immunol 23:2700-2703, 1993
46. Bogdan C, Vodovotz Y, Nathan C: Macrophage deactivation by interleukin-10. J Exp Med 174:1549-1555, 1991
47. Marchant A, Deviere J, Byl B, De Grotte D, Vincent J-L., Goldman M: Interleukin-10 production during septicemia. Lancet 1:707-708, 1994
48. Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaundry IH: Polymicrobial sepsis but not low dose endotoxin infusion causes decreased splenocyte IL2/IFN gamma release while increasing IL-4/IL-10 production. J Surg Res 56:574-585, 1994
49. Abraham E, Chang Y-H: Haemorrhage-induced alterations in function and cytokine production of T cells and T cell subpopulations. Clin Exp Immunol 90:497-502, 1992
50. Ayala A, Lehman DL, Herdon CD, Chaudry IH: Interleukin (IL)-10 induced suppression of T-cell responses following hemorrhage (HRM) is mediated by eicosanoids. Intens Care Med 20:S59, 1994
51. Miller-Graziano CL, De AK, Kodys K: Altered IL10 levels in trauma patients' MØ and T lymphocytes. J Clin Immunol 15:93-104, 1995